MD Anderson Cancer Center to Enter Partnership With Astex Pharmaceuticals, Inc.
September 09, 2020
September 09, 2020
HOUSTON, Texas, Sept. 9 (TNSPar) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 8:
The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announce a strategic collaboration agreement aimed at accelerating the clinical evaluation of Astex's pipeline of products for patients with certain types of leukemia, i . . .
The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announce a strategic collaboration agreement aimed at accelerating the clinical evaluation of Astex's pipeline of products for patients with certain types of leukemia, i . . .